Depression moderates the associations between beliefs about medicines and medication adherence in patients with rheumatoid arthritis: Cross-sectional study

Journal of Health Psychology

Volumn 23, Issue 9, 2018, Pages 1185-1195

  Brandstetter, Susanne ^a   Riedelbeck, Gertraud ^a   Steinmann, Mark ^a   Loss, Julika ^a   Ehrenstein, Boris ^b   Apfelbacher, Christian ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Asklepios Klinik Bad Abbach   (Germany)

Author keywords

beliefs about medicines; depression; medication adherence; rheumatoid arthritis

Indexed keywords

ADULT; AGED; ATTITUDE TO HEALTH; CROSS-SECTIONAL STUDY; DEPRESSION; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; PSYCHOLOGY; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED;

EID: 85050012543     PISSN: 13591053     EISSN: 14617277     Source Type: Journal    
DOI: 10.1177/1359105316646440     Document Type: Article

References (33)

1. Cabrera-Marroquin R, Contreras-Yanez I, Alcocer-Castillejos N. (2014) Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: The impact on disease outcomes. Clinical and Experimental Rheumatology 32(6): 904–913
2. Cosco TD, Doyle F, Ward M. (2012) Latent structure of the hospital anxiety and depression scale: A 10-year systematic review. Journal of Psychosomatic Research 72(3): 180–184
3. Covic T, Cumming SR, Pallant JF. (2012) Depression and anxiety in patients with rheumatoid arthritis: Prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (Dass) and the hospital, Anxiety and Depression Scale (Hads). BMC Psychiatry 12: 6
4. De Thurah A, Norgaard M, Harder I. (2010) Compliance with methotrexate treatment in patients with rheumatoid arthritis: Influence of patients’ beliefs about the medicine: A prospective cohort study. Rheumatology International 30(11): 1441–1448
5. Dimatteo MR, Lepper HS, Croghan TW, (2000) Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Archives of Internal Medicine 160(14): 2101–2107
6. Dougados M, Soubrier M, Antunez A. (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: Results of an international, cross-sectional study (Comora). Annals of the Rheumatic Diseases 73(1): 62–68
7. Fuchs J, Rabenberg M, Scheidt-Nave C, (2013) [Prevalence of selected musculoskeletal conditions in Germany: Results of the German health interview and examination survey for adults (Degs1)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56(5–6): 678–686
8. Hayes AF, (2012) Process: A versatile computational tool for observed variable mediation, moderation, and conditional process modeling [White Paper]. Available at: http://www.afhayes.com/public/process2012.pdf
9. Horne R, Weinman J, (1999) Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. Journal of Psychosomatic Research 47(6): 555–567
10. Horne R, Chapman SC, Parham R. (2013) Understanding patients’ adherence-related beliefs about medicines prescribed for long-term conditions: A meta-analytic review of the necessity-concerns framework. PLoS ONE 8(12): e80633
11. Horne R, Weinman J, Hankins M, (1999) The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health 14(1): 1–24
12. Mahler C, Hermann K, Horne R. (2010) Assessing reported adherence to pharmacological treatment recommendations: Translation and evaluation of the Medication Adherence Report Scale (Mars) in Germany. Journal of Evaluation in Clinical Practice 16(3): 574–579
13. Mahler C, Hermann K, Horne R. (2012) Patients’ beliefs about medicines in a primary care setting in Germany. Journal of Evaluation in Clinical Practice 18(2): 409–413
14. Matcham F, Rayner L, Steer S. (2013) The prevalence of depression in rheumatoid arthritis: A systematic review and meta-analysis. Rheumatology 52(12): 2136–2148
15. Matcham F, Scott IC, Rayner L. (2014) The impact of rheumatoid arthritis on quality-of-life assessed using the Sf-36: A systematic review and meta-analysis. Seminars in Arthritis and Rheumatism 44(2): 123–130
16. Meiran N, Diamond GM, Toder D. (2011) Cognitive rigidity in unipolar depression and obsessive compulsive disorder: Examination of task switching, stroop, working memory updating and post-conflict adaptation. Psychiatry Research 185(1–2): 149–156
17. Morris A, Yelin EH, Panopalis P. (2011) Long-term patterns of depression and associations with health and function in a panel study of rheumatoid arthritis. Journal of Health Psychology 16(4): 667–677
18. Neame R, Hammond A, (2005) Beliefs about medications: A questionnaire survey of people with rheumatoid arthritis. Rheumatology 44(6): 762–767
19. Nestoriuc Y, Orav EJ, Liang MH. (2010) Prediction of nonspecific side effects in rheumatoid arthritis patients by beliefs about medicines. Arthritis Care & Research 62(6): 791–799
20. Rathbun AM, Reed GW, Harrold LR, (2013) The temporal relationship between depression and rheumatoid arthritis disease activity, treatment persistence and response: A systematic review. Rheumatology 52(10): 1785–1794
21. Richetin J, Conner M, Perugini M, (2011) Not doing is not the opposite of doing: Implications for attitudinal models of behavioral prediction. Personality and Social Psychology Bulletin 31(1): 40–54
22. Smolen JS, Aletaha D, (2015) Rheumatoid arthritis therapy reappraisal: Strategies, opportunities and challenges: Nature reviews. Rheumatology 11(5): 276–289
23. Spruill TM, Ogedegbe G, Harrold LR. (2014) Association of medication beliefs and self-efficacy with adherence in urban his panic and African-American rheumatoid arthritis patients. Annals of the Rheumatic Diseases 73(1): 317–318
24. Treharne GJ, Lyons AC, Kitas GD, (2004) Medication adherence in rheumatoid arthritis: Effects of psychosocial factors. Psychology, Health and Medicine 9(3): 337–349
25. van den Bemt BJ, van den, Hoogen FH, Benraad B. (2009) Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs. Journal of Rheumatology 36(10): 2164–2170
26. van den Bemt BJ, Zwikker HE, van den Ende CH, (2012) Medication adherence in patients with rheumatoid arthritis: A critical appraisal of the existing literature. Expert Review of Clinical Immunology 8(4): 337–351
27. Vangeli E, Bakhshi S, Baker A. (2015) A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Advances in Therapy 32(11): 983–1028
28. Weightman MJ, Air TM, Baune BT, (2014) A review of the role of social cognition in major depressive disorder. Frontiers in Psychiatry 5: 179
29. Wells G, Becker JC, Teng J. (2009) Validation of the 28-joint disease activity score (Das28) and European league against rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the Das28 based on erythrocyte sedimentation rate. Annals of the Rheumatic Diseases 68(6): 954–960
30. Wisco BE, Nolen-Hoeksema S, (2010) Interpretation bias and depressive symptoms: The role of self-relevance. Behaviour Research and Therapy 48(11): 1113–1122
31. Zigmond AS, Snaith RP, (1983) The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 67(6): 361–370
32. Zwikker H, van den Bemt B, van den Ende C. (2012) Development and content of a group-based intervention to improve medication adherence in non-adherent patients with rheumatoid arthritis. Patient Education and Counseling 89(1): 143–151
33. Zwikker HE, Van Dulmen S, Den Broeder AA. (2014) Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis. Patient Preference and Adherence 8: 1635–1645